<DOC>
	<DOC>NCT00144651</DOC>
	<brief_summary>This is an open-label, extension, Phase II study to evaluate the long-term safety and efficacy of MRA in Patients with RA who were participated in Study MRA009JP.</brief_summary>
	<brief_title>Study of MRA in Patients With Rheumatoid Arthritis (RA)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Patients administered MRA more than 2 times in preceding study, MRA009JP, and evaluated the efficacy and the safety. Patients confirmed to have shown the safety in the preceding study. Patients with Class IV Steinbrocker functional activity at evaluation within 4 weeks before treatment with the study drug Patients who received any of the following treatments between the start of preceding study and the registration of this study. 1. Plasma exchange therapy 2. Surgical treatment (e.g., operation)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>